Suppr超能文献

碳青霉烯类药物帕尼培南的活性以及OprD(D2)蛋白在其通过铜绿假单胞菌外膜扩散中的作用。

Activity of the carbapenem panipenem and role of the OprD (D2) protein in its diffusion through the Pseudomonas aeruginosa outer membrane.

作者信息

Fukuoka T, Ohya S, Narita T, Katsuta M, Iijima M, Masuda N, Yasuda H, Trias J, Nikaido H

机构信息

Biological Research Laboratories, Sankyo Co., Ltd., Tokyo, Japan.

出版信息

Antimicrob Agents Chemother. 1993 Feb;37(2):322-7. doi: 10.1128/AAC.37.2.322.

Abstract

Evidence of permeation of panipenem through the OprD (D2) channel of Pseudomonas aeruginosa outer membrane was shown by using OprD protein-producing and -nonproducing strains which contained plasmid pHN4, which codes for L-1 beta-lactamase of Xanthomonas maltophilia. Permeation by panipenem was determined by measuring hydrolysis of the carbapenem by beta-lactamase in the periplasmic space. Permeation by panipenem was also determined by counting uptake of [14C]panipenem into P. aeruginosa PAO1 and its OprD protein-deficient mutant, and this permeation of PAO1 was inhibited by L-lysine. These results indicate that panipenem, as well as imipenem, uses the OprD channel, which functions as a specific channel for diffusion of basic amino acids. Panipenem and imipenem showed stronger activities against PAO1 and clinical isolates in human serum than in Mueller-Hinton broth, which contains more amino acids than human serum does. The activities of the carbapenems were reduced by addition of L-lysine to human serum. Similar results were obtained with mouse serum and ascitic fluid. In contrast, such a change in the activities of carbapenems was not observed with an OprD protein-deficient mutant, suggesting that the main reason for the strong activities of carbapenems in biological fluids is a decrease in competition between the antibiotics and basic amino acids for permeation through the OprD channel. Panipenem and imipenem showed much stronger therapeutic efficacies against experimental infections with P. aeruginosa in mice than did the reference antibiotics. Their in vivo activities were more consistent with their MICs in biological fluids than with those in Mueller-Hinton broth.

摘要

通过使用含有编码嗜麦芽窄食单胞菌L-1β-内酰胺酶的质粒pHN4的产OprD蛋白菌株和不产OprD蛋白菌株,证明了帕尼培南可透过铜绿假单胞菌外膜的OprD(D2)通道。通过测量周质空间中β-内酰胺酶对碳青霉烯的水解来确定帕尼培南的渗透情况。还通过计算[14C]帕尼培南进入铜绿假单胞菌PAO1及其OprD蛋白缺陷型突变体的摄取量来确定帕尼培南的渗透情况,并且PAO1的这种渗透被L-赖氨酸抑制。这些结果表明,帕尼培南与亚胺培南一样,利用OprD通道,该通道作为碱性氨基酸扩散的特异性通道。帕尼培南和亚胺培南在人血清中对PAO1和临床分离株的活性比对含有比人血清更多氨基酸的穆勒-欣顿肉汤中的活性更强。向人血清中添加L-赖氨酸会降低碳青霉烯类药物的活性。在小鼠血清和腹水中也获得了类似的结果。相比之下,在OprD蛋白缺陷型突变体中未观察到碳青霉烯类药物活性的这种变化,这表明碳青霉烯类药物在生物体液中活性强的主要原因是抗生素与碱性氨基酸在通过OprD通道渗透方面的竞争减少。帕尼培南和亚胺培南对小鼠铜绿假单胞菌实验性感染的治疗效果比参考抗生素强得多。它们的体内活性与其在生物体液中的最低抑菌浓度比与其在穆勒-欣顿肉汤中的最低抑菌浓度更一致。

相似文献

2
Effect of basic amino acids on susceptibility to carbapenems in clinical Pseudomonas aeruginosa isolates.
Int J Med Microbiol. 2003 Jun;293(2-3):191-7. doi: 10.1078/1438-4221-00256.
4
In vitro and in vivo evaluation of BO-2727 against imipenem- and/or meropenem-resistant Pseudomonas aeruginosa.
J Antibiot (Tokyo). 1997 Feb;50(2):135-8. doi: 10.7164/antibiotics.50.135.
5
Mutational inactivation of OprD in carbapenem-resistant Pseudomonas aeruginosa isolates from Korean hospitals.
J Microbiol. 2016 Jan;54(1):44-49. doi: 10.1007/s12275-016-5562-5. Epub 2016 Jan 5.
8
C-terminal region of Pseudomonas aeruginosa outer membrane porin OprD modulates susceptibility to meropenem.
Antimicrob Agents Chemother. 2001 Jun;45(6):1780-7. doi: 10.1128/AAC.45.6.1780-1787.2001.
10
Genetic definition of the substrate selectivity of outer membrane porin protein OprD of Pseudomonas aeruginosa.
J Bacteriol. 1993 Dec;175(24):7793-800. doi: 10.1128/jb.175.24.7793-7800.1993.

引用本文的文献

1
Genomic Analysis of Antimicrobial Resistance in from a "One Health" Perspective.
Microorganisms. 2024 Aug 27;12(9):1770. doi: 10.3390/microorganisms12091770.
3
Activity of zinc oxide and zinc borate nanoparticles against resistant bacteria in an experimental lung cancer model.
Daru. 2024 Jun;32(1):197-206. doi: 10.1007/s40199-024-00505-2. Epub 2024 Feb 17.
4
5
Escaping mechanisms of ESKAPE pathogens from antibiotics and their targeting by natural compounds.
Biotechnol Rep (Amst). 2022 Apr 4;34:e00728. doi: 10.1016/j.btre.2022.e00728. eCollection 2022 Jun.
6
Targeted Genome Reduction of Strain PAO1 Led to the Development of Hypovirulent and Hypersusceptible rDNA Hosts.
Front Bioeng Biotechnol. 2021 Mar 11;9:640450. doi: 10.3389/fbioe.2021.640450. eCollection 2021.
7
Antibiotic resistance and persistence-Implications for human health and treatment perspectives.
EMBO Rep. 2020 Dec 3;21(12):e51034. doi: 10.15252/embr.202051034. Epub 2020 Dec 8.
8
Host Environment Alters Susceptibility to Aminoglycoside Antibiotics.
Front Cell Infect Microbiol. 2017 Mar 14;7:83. doi: 10.3389/fcimb.2017.00083. eCollection 2017.
9
Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens.
Biomed Res Int. 2016;2016:2475067. doi: 10.1155/2016/2475067. Epub 2016 May 5.
10
Phenotypic heterogeneity enables uropathogenic Escherichia coli to evade killing by antibiotics and serum complement.
Infect Immun. 2015 Mar;83(3):1056-67. doi: 10.1128/IAI.02725-14. Epub 2015 Jan 5.

本文引用的文献

2
MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activities.
Antimicrob Agents Chemother. 1980 Jun;17(6):993-1000. doi: 10.1128/AAC.17.6.993.
3
Permeability of Pseudomonas aeruginosa outer membrane to hydrophilic solutes.
J Bacteriol. 1982 Nov;152(2):636-42. doi: 10.1128/jb.152.2.636-642.1982.
4
A simple method for the study in vivo of bacterial growth and accompanying host response.
J Infect. 1980 Mar;2(1):39-51. doi: 10.1016/s0163-4453(80)91773-9.
5
In-vitro and in-vivo antibacterial activity of imipenem against clinical isolates of bacteria.
J Antimicrob Chemother. 1983 Dec;12 Suppl D:53-64. doi: 10.1093/jac/12.suppl_d.53.
6
Imipenem therapy of Pseudomonas aeruginosa and other serious bacterial infections.
Antimicrob Agents Chemother. 1984 Nov;26(5):673-7. doi: 10.1128/AAC.26.5.673.
7
Postantibiotic effect of imipenem on Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 1984 Nov;26(5):678-82. doi: 10.1128/AAC.26.5.678.
8
Thienamycin: development of imipenen-cilastatin.
J Antimicrob Chemother. 1983 Dec;12 Suppl D:1-35. doi: 10.1093/jac/12.suppl_d.1.
9
Porin channels in Escherichia coli: studies with beta-lactams in intact cells.
J Bacteriol. 1983 Jan;153(1):232-40. doi: 10.1128/jb.153.1.232-240.1983.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验